147 related articles for article (PubMed ID: 34138523)
1. Healthcare resource utilization and costs among children with cystic fibrosis in the United States.
Thorat T; McGarry LJ; Bonafede MM; Limone BL; Rubin JL; Jariwala-Parikh K; Konstan MW
Pediatr Pulmonol; 2021 Sep; 56(9):2833-2844. PubMed ID: 34138523
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis.
Durieu I; Dalon F; Reynaud Q; Lemonnier L; Dehillotte C; Bérard M; Walther D; Viprey M; Van Ganse E; Belhassen M
J Cyst Fibros; 2022 Jan; 21(1):88-95. PubMed ID: 33865726
[TBL] [Abstract][Full Text] [Related]
3. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
5. Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007.
Briesacher BA; Quittner AL; Fouayzi H; Zhang J; Swensen A
Pediatr Pulmonol; 2011 Aug; 46(8):770-6. PubMed ID: 21465674
[TBL] [Abstract][Full Text] [Related]
6. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization costs of cystic fibrosis in the United States: a retrospective analysis.
Vadagam P; Kamal KM
Hosp Pract (1995); 2018 Oct; 46(4):203-213. PubMed ID: 30067115
[TBL] [Abstract][Full Text] [Related]
8. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
Amand C; Tong S; Kieffer A; Kyaw MH
BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
[TBL] [Abstract][Full Text] [Related]
9. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
10. The national cost of asthma among school-aged children in the United States.
Sullivan PW; Ghushchyan V; Navaratnam P; Friedman HS; Kavati A; Ortiz B; Lanier B
Ann Allergy Asthma Immunol; 2017 Sep; 119(3):246-252.e1. PubMed ID: 28890020
[TBL] [Abstract][Full Text] [Related]
11. Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019.
Howe SJ; Lapidus D; Hull M; Yeaw J; Stevenson T; Sampson JB
Orphanet J Rare Dis; 2022 Feb; 17(1):79. PubMed ID: 35197080
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
13. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
[TBL] [Abstract][Full Text] [Related]
14. Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin.
Gilligan AM; Franchino-Elder J; Song X; Wang C; Henriques C; Sainski-Nguyen A; Wilson K; Smith DM; Sander S
Expert Rev Pharmacoecon Outcomes Res; 2019 Apr; 19(2):203-212. PubMed ID: 30251553
[TBL] [Abstract][Full Text] [Related]
15. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.
Heimeshoff M; Hollmeyer H; Schreyögg J; Tiemann O; Staab D
Pharmacoeconomics; 2012 Sep; 30(9):763-77. PubMed ID: 22690685
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States.
Thorat T; McGarry LJ; Jariwala-Parikh K; Limone B; Bonafede M; Chandarana K; Konstan MW
Pulm Ther; 2021 Jun; 7(1):281-293. PubMed ID: 33913076
[TBL] [Abstract][Full Text] [Related]
17. Effects of variations in access to care for children with atopic dermatitis.
Siegfried EC; Paller AS; Mina-Osorio P; Vekeman F; Kaur M; Mallya UG; Héroux J; Miao R; Gadkari A
BMC Dermatol; 2020 Dec; 20(1):24. PubMed ID: 33341118
[TBL] [Abstract][Full Text] [Related]
18. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
19. Healthcare costs and resource utilization in patients with severe aplastic anemia in the US.
Cai B; Said Q; Li X; Li FY; Arcona S
J Med Econ; 2019 Oct; 22(10):1055-1062. PubMed ID: 31296074
[No Abstract] [Full Text] [Related]
20. Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US.
Miloh T; Goldstein A; Howard R; Mogul DB; Marden JR; Anderson A; Gaburo K; Kirson N; Rosenthal P
Liver Transpl; 2023 Jul; 29(7):735-744. PubMed ID: 36747344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
